Stopping the COVID-19 Pandemic: A Review on the Advances of Diagnosis, Treatment, and Control Measures

Table 1

A comparison of current diagnostic options for COVID-19.

Platform	Specimen/material	Type	Time	Sensitivity (%)	Specificity (%)	Cross-reactivity
NAAT	Nasopharyngeal swab; sputum; bronchoalveolar lavage fluid; blood	RT-PCR	240 mins	71–98	95	No
		CRISPR	40 mins	97	100	No
Serological	Nasopharyngeal swab; blood	Antibody	15–30 mins	92–100	93–100	Yes
		Antigen	15–30 mins	66–92	100	Yes
Imaging	Chest X-ray; Chest CT-scan	Radiologist	15–30 mins	74.6	93.8	NA
		AI	<5 mins	84.3	82.8	NA